Successful Deals with PwC: ADQ to acquire Swiss pharma company Acino

ADQ, one of Abu Dhabi’s largest holding companies, will acquire 100% of Acino from its current shareholders, Nordic Capital and Avista Capital Partners.

Acino is a Swiss-based leading provider of pharmaceuticals with presence in more than 90 countries across the Middle East, Africa, Latin America, Russia, Ukraine and the CIS Region. The company is a leader in more than 20 therapeutic areas including gastroenterology, cardiovascular and pain relief for high-quality pharmaceutical products in novel drug delivery forms.

Acino will be ADQ’s largest acquisition in its healthcare and pharma portfolio.

The PwC Deals team supported Acino and its current shareholders with Financial Vendor Due Diligence and a Tax Fact Book. 


The PwC team

Financial and Pension Vendor Due Diligence
  • Simon Bradford 
  • Luca Borrelli 
  • Leonor Lefebvre 
  • Felix Peters 
  • Markus Schneeberger 
  • Kristi Leibur-Nagel 
  • Andreas Schuler 
  • Janko Mahecic
Tax Fact Book
  • Claire Manders Avanzini
  • Ariel Gruenewald
Support from PwC South Africa and Ukraine teams.

 

Successful Deals with PwC

{{filterContent.facetedTitle}}

{{contentList.dataService.numberHits}} {{contentList.dataService.numberHits == 1 ? 'result' : 'results'}}
{{contentList.loadingText}}

Contact us

Luca Borrelli

Luca Borrelli

Partner, Pharma and Life Sciences, PwC Switzerland

Tel: +41 58 792 22 78